financetom
Business
financetom
/
Business
/
US State Dept says oil service firm SLB is not violating Russia sanctions
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US State Dept says oil service firm SLB is not violating Russia sanctions
May 1, 2024 10:10 AM

HOUSTON, May 1 (Reuters) - The U.S. State Department

believes oil services firm SLB has not violated

sanctions against Russia and the company has been told what

Washington is willing to accept, Assistant Secretary of State

Geoffrey Pyatt told Reuters in an interview on Wednesday.

"I have had conversations with the CEO of that company... I

think there is a clear understanding within SLB in terms of

where the guard rails are on the sanctions policy," Pryatt said.

Since Russia invaded Ukraine, the U.S. and other western

countries have sought to reduce Moscow's energy revenue through

sanctions that prompted many service companies to leave Russia.

SLB has helped Russia keep oil flowing, generating money to fund

the war.

"I am confident from my conversations with Treasury

colleagues that SLB's actions thus far have been in conformance

with rules that OFAC, Treasury and the price cap coalition have

set up," Pyatt said.

The U.S. is determined to ensure Russia does not return to

being a reliable energy partner and Washington will continue to

sanction present and future energy projects, while taking care

not to cause oil price shocks, said Pyatt.

SLB was not immediately available for comment. The company

had 10,000 employees in Russia helping Gazprom Neft, Rosneft and

other top energy firms pump more oil and gas when the war began

in 2022 and is the world's largest oil services and equipment

provider.

The U.S Treasury is also going after shippers, insurance

companies and others that circumvent the sanctions, said Pyatt.

He said Russia's oil and gas tax revenue is down about a

third year on year.

Washington is also targeting Russia's future energy

projects, including liquefied natural gas (LNG), seeking to

prevent Russia from sending the gas that previously flowed to

European customers via pipeline to global markets as LNG, said

Pyatt.

"So you have seen very strong sanctions against Novatek and

there is more to come in the short term on that score," he told

Reuters.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Tesla's sales in Sweden fall 53.7% year-on-year in May
Tesla's sales in Sweden fall 53.7% year-on-year in May
Jun 2, 2025
STOCKHOLM (Reuters) -Tesla's new car sales in Sweden fell 53.7% in May from a year earlier to 503 vehicles, registration data from Mobility Sweden showed on Monday. ...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Sanofi to buy US biopharma group Blueprint for over $9 billion
Sanofi to buy US biopharma group Blueprint for over $9 billion
Jun 2, 2025
* Sanofi to pay $129 per share in cash * Deal to enhance Sanofi's rare and immunology portfolios * Would be one of biggest in Europe so far this year (Adds details and background throughout, shares) PARIS, June 2 (Reuters) - France's Sanofi has agreed to buy U.S.-based Blueprint Medicines Corporation ( BPMC ) for over $9 billion to boost...
Novartis' Pluvicto shown to slow prostate cancer in earlier setting
Novartis' Pluvicto shown to slow prostate cancer in earlier setting
Jun 2, 2025
FRANKFURT (Reuters) -Novartis said on Monday that its targeted radiotherapy Pluvicto was shown to slow progression of a certain type of prostate cancer, raising the prospect of treatment in an earlier disease stage for a drug technology that the drugmaker has pioneered. The Swiss drugmaker reported a late-stage trial showed a clinically meaningful benefit in progression-free survival with a positive...
Copyright 2023-2026 - www.financetom.com All Rights Reserved